Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease

Status unconfirmed

Conditions studied: Epithelial Ovarian Cancer

In brief

Blood samples and Tumor tissue will be collected at certain timepoints and will be tested.

Key facts

Study ID

NCT05212779

Run by

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

People needed

45

Starts

2022-10-07

Expected to finish

2024-12-30

Last updated by the study team

2024-02-01

Who can join

Age: 18 and older, up to 95. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of epithelial ovarian cancer stage II-IV

You may not qualify if…

• Insufficient tumor to perform Signatera testing; Inability to provide consent for the trial

Where it is running

• AHN West Penn Hospital — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.